Background: The cystic fibrosis transmembrane conductance regulator gene (CFTR) shows a complex pattern of expression. The regulatory elements conferring tissue-specific and temporal regulation are thought to lie mainly outside the promoter region. Previously, we identified DNase I hypersensitive sites (DHS) that may contain regulatory elements associated with the CFTR
Introduction
Transcription of the cystic fibrosis transmembrane conductance regulator (CFTR) gene (1) is tightly regulated both spatially and temporally. Its expression is limited primarily to specific epithelial cell types within the respiratory system, the small intestine and colon, pancreas and gall bladder, kidney, genital ducts, and sweat glands (2) (3) (4) (5) (6) . In the postnatal airway, highest levels of CFTR mRNA are detected in the serous portion of submucosal glands with low levels in the surface epithelium (6) . In the intestine, CFTR mRNA is seen primarily in the crypt cells with gradients of expression decreasing along the crypt-villus axis and from the small intestine to the large intestine (5) . CFTR mRNA and protein are found in the ductal epithelium of the pancreas and gall blad-der and possibly also in pancreatic acini (4) . Temporal regulation of CFTR transcription is seen in the airway where abundant CFTR transcription throughout the epithelium of the fetus decreases substantially after birth (7, 8) . CFTR expression in the reproductive tract is also cyclical in some species (9, 10) .
Relatively little is known of the mechanisms underlying this strict cellular control of CFTR expression, and there is no consistent evidence for tissue-specific control elements in the promoter (11) (12) (13) . We searched for regulatory elements in the CFTR genomic DNA outside the immediate promoter region by looking for DNase I hypersensitive sites (DHS) that are often associated with sequence elements involved in the regulation of transcription. We identified three DHS in the CFTR gene, two in the 5' flanking sequence (-79.5 kb and -20.5 kb with respect to the CFTR ATG), and one in intron 1 (at 185 + 10 kb, where 185 refers to the last base in exon 1) (14, 15) . These DHS were identified in human cell lines and cultured primary human genital duct cells that express endogenous CFTR. The sites at -79.5 and -20.5 kb showed no correlation with CFTR expression in the cell types investigated, although they may still play a role in the complex series of events involved in the regulation of CFTR transcription. The 185 + 10 kb DHS showed complete correlation with CFTR expression only being evident in cells that express CFTR and not in those that lacked CFTR expression (15, 16) . In vitro analysis of binding of proteins to this region by electromobility shift assays (EMSA) and DNase I footprinting revealed that some proteins that are only present in CFTRexpressing cells bound to specific elements. When assayed by transient expression in a cell line expressing endogenous CFTR, the element at 185 + 10 kb augmented reporter gene expression under the control of the CFTR promoter but had no effect in nonexpressing cells (1 5) . In vitro evaluation of regulatory elements in a large complex gene such as CFTR can only generate limited data, primarily because chromatin-mediated effects are difficult to reproduce. Our aim here was to use transgenic mice carrying the human CFTR gene, on a yeast artificial chromosome (YAC), to evaluate whether regulatory elements at the -79.5, -20.5, and 185 + 10 kb are important for CFTR expression in vivo.
A 310 kb YAC containing the intact human CFTR gene [37AB12, (17) ] has previously been introduced into transgenic mice (18) . The transgenic mice were bred with the "Cambridge" CF null mice to produce mice that only express the human CFTR transgene (18 
Materials and Methods
Cosmid Clones for YAC Mapping Probes ( Fig. 1) were derived from the cosmid contig described in the original CFTR cloning paper (19) and were kindly donated by Dr. Joanna Rommens.
Transgenic Mice Details of generation of the mice carrying the 37AB12 YAC and crosses with the "Cambridge" null mice have been described previously (18) . The mice used in this study were homozygous for the YAC transgene and for the CF knockout. Mouse tissues were collected immediately after death and placed in liquid nitrogen for RNA extraction or processed directly for chromatin extraction. Only data from the T30 strain of transgenic mice are presented here. RNA Extraction sion by . The locations of primers Total RNA was extracted from transgenic mouse used for RT-PCR are shown in Table 2 and tissues, normal mouse ileum, and Calu3 cells by described in detail elsewhere (22, 23 (24) . Each batch of chromatin Reverse Transcriptase-PCR (RT-PCR) was tested with the RA2.2 probe that detects a All tissues studied were evaluated for transcripconstitutive DHS in the human and mouse tion of human and mouse CFTR mRNA expresa-globin gene cluster (25) . The DHS at -20.5 kb Final mapping data for the 5' end of the YAC were provided by hybridization of various probes to Southern blots of YAC DNA. The pB14E4.9 probe (Fig. IA) did not hybridize to HindIll-digested YAC DNA (Fig. 2B) , whereas the pB14E5.3 probe (Fig. LA) Analysis of Transgene Expression RT-PCR was used to detect CFTR mRNA from transgenic mouse duodenum, ileum, kidney, liver, lung, pancreas, spleen, and testis and genital ducts combined (Fig. 3) . In addition, the RT 3A, C , and E). The normal mouse ileum negative control reactions showed that the primers were specific for human CFTR mRNA (lanes labeled NM in Fig. 3A , C, and E). All RT-PCR reactions were accompanied by no-RNA and noreverse transcriptase controls (Fig. 3B, D, and F) . Mouse ,3-actin primers were used to check that RNA in each sample could be amplified by RT-PCR (Fig. 3G) .
Chromatin Extraction
Three sets of human CFTR-specific primers were used for RT-PCR, AIR/6SIL, CIR/C2L, and FIR/F2L ( Table 2 ). The primers were derived from the human CFTR cDNA sequence but have strong homology to the equivalent mouse sequence (see Table 2 ). However, none of them generated a product from normal mouse ileum RNA. All products obtained using the humanspecific primers on transgenic mouse RNA were therefore amplified from the human transgene. This was further validated by complete digestion of the RT-PCR products using enzymes with recognition sites only in the human and not the relevant mouse fragment.
The primers AIR and 6S1L, located in exons 1 and 6, respectively, amplified a product of the expected size in samples from transgenic duodenum, ileum, lung, and pancreas whereas no product was seen in samples from kidney, liver, spleen, and testis and genital ducts (Fig. 3A) . The num, ileum, lung, pancreas, and testis and genital ducts whereas no product was seen in samples from kidney, liver, or spleen (Fig. 3C) . The primers FIR and F2L, located in exons 19 and 24, respectively, amplified a product of the expected size in samples from transgenic duodenum, ileum, lung, pancreas, and testis and genital ducts whereas no product was seen in samples from kidney, liver, or spleen (Fig. 3E) . These results are summarized in Table 3 and show that the human CFTR transgene is expressed in duodenum, ileum, lung, and pancreas but not in kidney, liver, and spleen. Expression in the testis and genital ducts was observed with the primers CIR/C2L and FIR/F2L but not with primers A1R/6S1L. Detection of the DNase I Hypersensitive Site at -20.5 kb The same tissues that had been analyzed by RT-PCR for CFTR RNA expression were also analyzed by DNase I digestion of chromatin to detect DHS. The efficiency of the DNase I digestion was confirmed by hybridizing filters carrying BamHIcleaved DNA from each tissue with the RA2.2 probe (25) which recognizes a constitutive DHS in the mouse a-globin gene cluster.
The DHS at -20.5 kb was detected with the cW44H 1.1 probe (Fig. 1 B) as shown previously with chromatin extracted from human primary cells and cell lines (14) . This probe hybridizes to an EcoRI restriction fragment of 4.9 kb in intact chromatin and detects a subfragment of 3.5 kb, and occasionally another subfragment of 3 kb, in chromatin treated with DNase I (14) . Chromatin from transgenic mouse tissues was examined for the presence of the -20.5 kb DHS (Fig. 4) . The intact 4.9 kb EcoRI restriction fragment was seen in all tissues. A 3.5 kb subfragment appeared in chromatin from kidney ( Fig. 4A) , colon ( Fig. 4D ), small intestine (Fig. 4E) , and stomach (Fig. 4F) . Two subfragments, of about 3.5 kb and 2.8 kb, were seen in liver (Fig. 4B) (18) . A subfragment of 8 kb was seen in kidney (Fig. 5A) , liver (Fig. 5B) , and small intestine (Fig. SD) . The presence of this 8 kb fragment in intestinal chromatin that had not been treated with DNase I (Fig. 5D (Fig. SF) . A summary of the DHS results is presented in Table 3 .
Discussion
The data presented here provide the first in vivo analysis of potential regulatory elements located at -20.5 kb with respect to the ATG and at 10 kb into the first intron of the human CFTR gene. By using a YAC carrying the intact human CFTR (18) argues against position effects of neighboring chromatin playing a significant role in CFTR expression and the DHS in these mice. The DHS that was previously detected at -79.5 kb was not present on the YAC. As the YAC expresses well in the small intestine and salivary glands of transgenic mice, this indicates that the -79.5 kb DHS is not important for expression in these tissues. However, it could be important for expression in such tissues as the kidney, and Brunner's glands (18) , where expression of the gene from the YAC is not found. The two regions at -20.5 kb and 185 + 10 kb in the YAC were both able to form DHS in some tissues in the transgenic mice. This indicates that the mouse transcriptional machinery is able to A. Kidney interact with these sites and that they are probably important for CFTR gene expression.
An initial investigation of human CFTR transgene expression in the CF knockout mice by mRNA in situ hybridization (18) showed abundant expression in the crypts of the small intestine with a decreasing gradient from the duodenum to the colon, as well as in salivary glands within the ductal epithelium and mucous acini. No CFTR transgene expression was seen in the pancreas, lung, or Brunner's glands. In the present study human CFTR mRNA was detected by RT-PCR in the small intestine, lung, pancreas, testis and genital ducts but not in the kidney, liver, or spleen. The results for the lung and pancreas are of interest as it was not clear from the in situ hybridization data whether there was any expression of the human transgene in these tissues. The positive results for the lung and pancreas by RT-PCR could be due to the increased sensitivity of RT-PCR over mRNA in situ hybridization (18) .
We consistently detected human CFTR mRNA in testis and genital ducts using primers for exons 11 The 185 + 10 kb DHS is not present in chromatin extracted from transgenic mouse pancreas. In humans, CFTR expression levels are very high in pancreatic duct cells (2, 4, 5) and the 185 + 10 kb DHS has been observed in a human pancreatic adenocarcinoma cell line (Capanl) that expressed low levels of CFTR (15) . However, mice show very low levels of pancreatic CFTR expression (9) and the transgenic mice show low levels of human transgene expression in the pancreas (undetectable by mRNA in situ hybridization). It is possible that only a small percentage of cells (for example, certain ductal epithelial cells) in the transgenic mouse pancreas express the human CFTR gene at a high level and that they contribute too small a fraction to the total tissue chromatin for the DHS to be detected. Alternatively, the -20.5 kb DHS, which is present in pancreatic chromatin from the transgenic mice, might be involved in the low-level expression detected in the transgenic mouse pancreas by RT-PCR, while the 185 + 10 kb site might contain a regulatory element involved in the high levels of CFTR gene expression normally seen in human pancreatic duct cells. The lack of the 185 + 10 kb site in the mouse chromatin (probably due to the lack of appropriate transcription factors) would then explain the lack of high-level expression in the mouse pancreas.
Similarly, the 185 + 10 kb DHS is not present in chromatin extracted from transgenic mouse lung. The CFTR gene is normally ex-pressed at low levels in the surface epithelium of the adult human lung, with higher levels in the serous portion of submucosal glands (6 The results from the testis and genital ducts, in which the human YAC CFTR transgene was expressed but neither the -20.5 kb or 185 + 10 kb DHS were evident, suggest that neither of these regions is important in testis or genital duct expression. Human testis exhibits low and diffuse levels of CFTR expression, which does not appear to be associated with any specific cell type (30) . In contrast, CFTR is expressed at higher levels in the epithelium of the seminiferous tubules of mouse testis at all stages of spermatogenesis (9) . CFTR is also known to show specific temporal regulation of expression in the male and female reproductive systems in rodents (10) . Control of expression in these tissues may be operating through different regulatory elements.
In conclusion, the data provide evidence for the in vivo importance of the DHS at -20.5 kb as this site is present in chromatin from most of the transgenic mouse tissues. The 185 + 10 kb DHS has a more restricted distribution and is not found in lung or pancreatic tissues of the transgenic mice. The lack of formation of this DHS might be responsible for the very low levels of CFTR expression in the mouse lung and pancreas, which would indicate that the 185 + 10 kb DHS is important for the higher levels of expression in these human tissues. Finally, neither DHS is present in chromatin from testis or genital ducts, and expression in these tissues may be operating through other regulatory elements that have not been identified but that are present on the YAC.
However, the results also illustrate the problems of using the mouse as a model for investigation of the subtleties of human CFTR tissuespecific regulation. The CFTR gene shows a divergent pattern of expression in rodents (9) and humans (2) (3) (4) (5) (6) . The data presented here show that the murine transcriptional machinery can interact with the -20.5 and 185 + 10 kb DHS and give adequate levels of CFTR mRNA expression in many tissues. However, lack of transgene expression in certain other sites, such as the kidney and Brunner's glands, might result from the incompatibilities between the mouse and human transcriptional control mechanisms for CFTR. Analysis of the promoter regions of the human, mouse, and rat CFTR genes has shown them to be highly divergent (31, 32) . Although some putative regulatory elements are loosely conserved, most of them are species-specific. A more extensive cross-species comparison of the CFTR promoter region (33) from eight mammalian species including human, monkey, cow, rabbit, mouse, and rat suggests that the cow and rabbit might be more suitable models in which to analyze human CFTR gene regulation in vivo. Recent advances in cloning technology (34) (35) (36) will enable this type of analysis to be carried out in ovine models, which are known to show a pattern of CFTR gene expression and regulation that is very similar to that of the human gene (37, 38) .
